Entrada Therapeutics (TRDA) Stock Chart & Stock Price History $17.60 +0.46 (+2.68%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Entrada Therapeutics Stock Price Performance5 Day Performance+1.32%1 Month Performance+8.04%3 Month Performance+19.32%6 Month Performance+29.79%Year-To-Date Performance+16.63%1 Year Performance+12.32% Receive TRDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Opportunistic TraderMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...For a limited time, he's revealing his latest forecast here. TRDA Stock Chart for Saturday, November, 2, 2024 TRDA Chart by TradingView Entrada Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$17.14$17.60+2.68%$17.86$17.1683,564 shs$654.72 million10/31/2024$17.23$17.14-0.52%$17.34$17.0473,841 shs$637.61 million10/30/2024$17.28$17.23-0.29%$17.54$17.0858,152 shs$640.96 million10/29/2024$17.37$17.28-0.52%$17.64$16.9677,284 shs$642.82 million10/28/2024$16.99$17.37+2.24%$17.75$17.1766,142 shs$646.16 million10/25/2024$16.84$16.99+0.89%$17.74$16.9979,489 shs$632.03 million Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$16.97$16.84-0.77%$17.42$16.8140,662 shs$626.45 million10/23/2024$17.13$16.97-0.93%$17.17$16.8180,067 shs$572.89 million10/22/2024$17.32$17.13-1.10%$17.52$16.8989,338 shs$637.24 million10/21/2024$17.44$17.32-0.69%$17.49$16.8680,615 shs$644.30 million10/18/2024$17.63$17.44-1.08%$17.80$17.3157,949 shs$648.77 million10/17/2024$17.66$17.63-0.17%$17.78$17.1862,337 shs$655.84 million10/16/2024$17.53$17.66+0.74%$18.01$17.54108,675 shs$596.18 million10/15/2024$17.83$17.53-1.68%$18.00$17.50150,683 shs$591.80 million10/14/2024$16.78$17.83+6.26%$17.88$16.47147,608 shs$663.28 million10/11/2024$15.81$16.78+6.14%$16.82$15.68186,586 shs$566.48 million10/10/2024$16.17$15.81-2.23%$16.22$15.65160,270 shs$588.13 million10/09/2024$16.39$16.17-1.34%$16.45$15.94213,366 shs$601.52 million10/08/2024$16.54$16.39-0.91%$16.69$16.2593,016 shs$553.31 million10/07/2024$17.07$16.54-3.10%$17.30$16.48101,032 shs$558.37 million10/04/2024$16.44$17.07+3.83%$17.20$16.6899,438 shs$576.27 million10/03/2024$16.29$16.44+0.92%$16.71$15.98159,121 shs$611.57 million10/02/2024$16.00$16.29+1.81%$16.42$15.53111,198 shs$605.99 million10/01/2024$15.98$16.00+0.13%$16.02$15.19159,388 shs$595.20 million09/30/2024$16.45$15.98-2.86%$16.66$15.59158,789 shs$539.47 million09/27/2024$15.77$16.45+4.31%$17.38$15.87342,408 shs$611.94 million09/26/2024$15.05$15.77+4.78%$16.16$15.11167,567 shs$532.38 million09/25/2024$15.40$15.05-2.27%$15.49$15.0079,299 shs$508.07 million09/24/2024$14.57$15.40+5.70%$15.44$14.49187,901 shs$519.89 million09/23/2024$14.68$14.57-0.75%$14.90$14.48221,638 shs$491.87 million09/20/2024$15.00$14.68-2.13%$15.09$14.55418,311 shs$495.58 million09/19/2024$13.65$15.00+9.89%$15.38$14.09138,023 shs$558 million09/18/2024$14.16$13.65-3.60%$14.26$13.46240,490 shs$460.81 million09/17/2024$14.55$14.16-2.68%$14.58$13.90160,008 shs$478.03 million09/16/2024$15.00$14.55-3.00%$15.42$14.5078,095 shs$491.19 million09/13/2024$14.86$15.00+0.94%$15.19$14.94122,108 shs$558 million09/12/2024$14.86$14.86$15.23$14.6774,851 shs$501.66 million09/11/2024$14.72$14.86+0.95%$15.03$14.5474,286 shs$501.66 million09/10/2024$15.03$14.72-2.06%$15.05$14.5897,035 shs$547.58 million09/09/2024$14.80$15.03+1.55%$15.33$14.70124,396 shs$559.12 millionCrypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now.09/06/2024$15.39$14.80-3.83%$15.63$14.6282,033 shs$550.56 million09/05/2024$15.40$15.39-0.06%$15.58$14.9988,867 shs$572.51 million09/04/2024$15.65$15.40-1.60%$15.87$15.04145,085 shs$572.88 million09/03/2024$17.70$15.65-11.58%$17.75$15.44127,834 shs$582.18 million09/02/2024$17.70$17.70$17.84$17.08177,900 shs$597.53 million08/30/2024$17.50$17.70+1.14%$17.84$17.08177,913 shs$658.44 million08/29/2024$16.32$17.50+7.23%$17.59$16.39145,570 shs$651 million08/28/2024$16.70$16.32-2.28%$16.85$16.1474,597 shs$550.95 million08/27/2024$16.91$16.70-1.24%$16.89$16.5859,480 shs$621.24 million08/26/2024$16.52$16.91+2.36%$17.01$16.43155,437 shs$629.05 million08/23/2024$16.11$16.52+2.55%$16.64$15.99119,789 shs$557.70 million08/22/2024$16.46$16.11-2.13%$16.65$16.0675,737 shs$599.29 million08/21/2024$16.93$16.46-2.78%$17.11$16.36165,099 shs$612.31 million08/20/2024$16.52$16.93+2.48%$17.00$16.32164,104 shs$571.54 million08/19/2024$16.53$16.52-0.06%$16.63$16.12467,115 shs$557.70 million08/16/2024$16.26$16.53+1.66%$16.72$15.78242,610 shs$558.04 million08/15/2024$15.82$16.26+2.78%$16.61$15.96105,272 shs$548.92 million08/14/2024$15.81$15.82+0.06%$16.00$15.3185,321 shs$534.07 million08/13/2024$14.21$15.81+11.26%$15.93$14.68117,732 shs$533.75 million08/12/2024$14.02$14.21+1.36%$14.63$13.71135,969 shs$479.72 million08/09/2024$14.45$14.02-2.98%$14.69$13.7696,806 shs$473.32 million08/08/2024$13.81$14.45+4.63%$14.45$13.8288,515 shs$487.82 million08/07/2024$14.69$13.81-5.99%$14.89$13.71109,037 shs$466.21 million08/06/2024$14.46$14.69+1.59%$15.04$14.1553,057 shs$495.92 million08/05/2024$14.75$14.46-1.97%$14.57$13.64130,662 shs$488.16 million08/02/2024$15.96$14.75-7.58%$15.45$14.49118,201 shs$497.96 million08/01/2024$16.47$15.96-3.10%$16.66$15.86322,323 shs$538.81 million Related Companies Catalyst Pharmaceuticals Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart CG Oncology Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart ImmunityBio Stock Price Chart ACADIA Pharmaceuticals Stock Price Chart 23andMe Stock Price Chart Scholar Rock Stock Price Chart Longboard Pharmaceuticals Stock Price Chart IDEAYA Biosciences Stock Price Chart Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRDA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entrada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.